Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)

NCT02657707 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.

NCT NCT02657707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Lead sponsor
Microvention-Terumo, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 21, 2016
Completion date
May 31, 2024
Enrollment
295 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery stenosis